Prognostic Indicators in Cancer Outcomes
Summary
Cancer prognosis relies increasingly on biomarkers that integrate measures of systemic inflammation, nutritional status and immune competence. Traditional staging systems such as the TNM classification remain pivotal, but their predictive accuracy can be enhanced by composite indices derived from routine laboratory parameters. These include scores that combine haemoglobin, albumin, lymphocyte and platelet counts, or that reflect the balance between pro-inflammatory and anti-inflammatory signals. Recent work has focused on refining these indices, validating them across tumour types and integrating them into prognostic nomograms. Such tools can stratify patients more precisely, inform personalised treatment decisions and identify individuals at risk of poor outcomes, thereby guiding nutritional, anti-inflammatory or immunomodulatory interventions alongside standard oncological care.
Research from Nature Portfolio
An early study established the prognostic utility of a combined haemoglobin–albumin–lymphocyte–platelet (HALP) score in patients undergoing radical cystectomy for bladder cancer. Investigators demonstrated that a lower preoperative HALP value was independently associated with reduced overall survival and that a nomogram incorporating HALP, age, American Society of Anesthesiologists grade and TNM stage outperformed TNM alone in predictive accuracy. This work laid the foundation for the adoption of composite immunonutritional scores as standard risk-stratification tools in surgical oncology.
Prognostic Indicators in Cancer Outcomes publication trend
The graph below shows the total number of articles in prognostic indicators in cancer outcomes across all publications each year (not limited to Nature Index journals).
Technical terms
HALP score: Composite index combining haemoglobin, albumin, lymphocyte and platelet counts to gauge immunonutritional status.
CALLY index: Prognostic metric incorporating C-reactive protein, albumin and lymphocyte levels to reflect inflammation and nutrition.
GRIm score: Immune score based on albumin concentration, neutrophil-to-lymphocyte ratio and lactate dehydrogenase designed to predict survival.
Nomogram: Graphical tool that integrates multiple prognostic factors to estimate the probability of a clinical event.
TNM stage: Standard classification system denoting tumour size (T), nodal involvement (N) and presence of metastasis (M).
References
- Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Frontiers in Immunology (2023).
- Prognostic significance of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in breast cancer: a propensity score-matching study. Cancer Cell International (2024).
- Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis. Annals of Medicine (2023).
- Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy. Scientific Reports (2018).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.